Skip to main content

Advertisement

Log in

Maxamine™

Histamine Dihydrochloride

  • Section 2: Depatitis C
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Maxim Pharmaceuticals announces phase II hepatitis C clinical trial planned for Spring 1998 positive safety data reported in phase I trial. PR Newswire [online]. 1998 Jan 15. URL: http://www.newspage.com [Accessed on 1998 Jan 15]

  2. Maxim Pharmaceuticals. Maxim Pharmaceuticals announces preliminary results from phase I study in hepatitis C patients. [press Release]. Maxim Pharmaceuticals [online]. 1998 Jun 10. URL: http://www.maxim.com [Accessed on 1998 Jun 10]

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maxamine™. Drugs R&D 2, 274–275 (1999). https://doi.org/10.2165/00126839-199902040-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902040-00014

Keywords

Navigation